Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00111449
What this trial is testing

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Who this might be right for
Psoriasis
Amgen 600
Testing effectiveness (Phase 2)Ended earlyNCT02243787
What this trial is testing

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Covagen 24
Large-scale testing (Phase 3)Study completedNCT06049810
What this trial is testing

IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 566
Large-scale testing (Phase 3)Study completedNCT01008995
What this trial is testing

The Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 322
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Testing effectiveness (Phase 2)Study completedNCT02933502
What this trial is testing

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT02173301
What this trial is testing

Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 200
Post-approval studies (Phase 4)Study completedNCT00312026
What this trial is testing

Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

Who this might be right for
Psoriasis
Genentech, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT03832738
What this trial is testing

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 152
Large-scale testing (Phase 3)Study completedNCT01406938
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 967
Early research (Phase 1)Study completedNCT02534636
What this trial is testing

Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis

Who this might be right for
Healthy Subjects
Bristol-Myers Squibb 140
Post-approval studies (Phase 4)Study completedNCT01722214
What this trial is testing

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Who this might be right for
PsoriasisVascular InflammationCoronary Atherosclerosis
Innovaderm Research Inc. 107
Large-scale testing (Phase 3)Study completedNCT01597245
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,224
Not applicableStudy completedNCT05344482
What this trial is testing

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 277
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Testing effectiveness (Phase 2)Study completedNCT01837420
What this trial is testing

Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

Who this might be right for
Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 194
Testing effectiveness (Phase 2)Looking for participantsNCT06592274
What this trial is testing

HB0017 in Psoriasis Patients

Who this might be right for
Psoriasis (PsO)
Huabo Biopharm Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT05509361
What this trial is testing

Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 950
Post-approval studies (Phase 4)Study completedNCT05478499
What this trial is testing

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 154
Testing effectiveness (Phase 2)Study completedNCT02054481
What this trial is testing

BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab

Who this might be right for
Psoriasis
Boehringer Ingelheim 166
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation